Bullous Keratopathy Market is set to Grow at a Remarkable Pace by 2033

Posted by Ganesh Shinde on March 2nd, 2023

The global bullous keratopathy market is expected to register a CAGR of 4.3% from 2023 to 2033, reaching a valuation of US$ 427.54 Million in 2023, as per a recently published Future Market Insights report. The rising prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the industry's growth. According to the NCBI report, approximately 10-15% of patients diagnosed with keratoconus require to undergo a corneal implant procedure at some point.

Corneal blindness is the third-leading cause of blindness after glaucoma and cataract affecting 10 million people globally.The most common cause of damage to endothelium layer of the cornea is eye surgery. Any kind of trauma, glaucoma, or inflammation from eye surgery can result in bullous keratopathy. Bullous keratopathy may occur in around 1% to 2% of patients undergoing cataract surgery, a nonsignificant number when you consider that approximately 10 million patients undergo cataract surgery worldwide each year.

Collagen-based bio-engineered artificial corneas used in Bullous Keratopathy have high demand in the market owing to their advantages, such as low cost, biocompatibility, and improved safety and effectiveness. There has been an increased focus of manufacturers to develop and launch new products. Currently, two products are in clinical trials and are expected to help the artificial cornea segment and overall industry growth over the forecast period. For instance, in 2022, Corneat Vision announced that its CorNeat KPro (artificial cornea) is undergoing clinical trials. This product is expected to receive marketing approval in 2024 which will aid in the market expansion of Bullous Keratopathy.

Competitive Landscape

Key players in the Bullous Keratopathy market are- Hoffmann-La Roche Ltd, Regeneron, Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Cellusion, CRSTEurope, Barraquer Eye Hospital, Planchard Eye & Laser Center, Medscape.

Browse More Details@ https://www.futuremarketinsights.com/reports/bullous-keratopathy-market

Key Segments Profiled in the Bullous Keratopathy Market Industry Survey

Bullous Keratopathy Market by Therapies:

• Emmecell
• Drug Description
• Regulatory Milestones
• Safety and Efficiency
• Product Profile
• Cellusion
• Drug Description
• Other Development Activities
• Clinical Development
• Safety and Efficiency
• Product Profile

Bullous Keratopathy Market by End User:

• Hospitals
• Surgical Centers

Bullous Keratopathy Market by Treatment:

• Medical Management
• Lubricants
• Steroids
• Hyperosmotic agents
• Anti- Glaucoma drugs
• Antibiotics
• Amniotic Membrane Grafting (AMG)
• Annular Keratotomy
• Anterior Stromal Puncture